Can This Biotech Wow Wall Street?

Ariad Pharmaceuticals (NASDAQ: ARIA  ) gained approval from the Food and Drug Administration for its chronic myeloid leukemia drug Iclusig in mid-December. The drug is currently approved for patients who don't respond to treatment with Novartis' (NYSE: NVS  ) Gleevec, Tasigna, or Bristol-Myers Squibb's (NYSE: BMY  ) Sprycel. With FDA approval now complete, the big question mark hanging over Ariad in 2013 is whether its Iclusig launch will be successful. In this video, analyst Max Macaluso weighs in and highlights issues that investors need to watch this year.

What's inside Supernova?
If you're an investor looking for big long-term winners, Motley Fool co-founder David Gardner's picks have frequently trounced the market. How? Because he's always on the lookout for revolutionary stocks and recommends them before Wall Street catches on to their disruptive potential. If you're interested in how David discovers his winners, click here to get instant access to a personal tour behind David's Supernova service.

Read/Post Comments (1) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 11, 2013, at 5:31 PM, biotechnique wrote:

    Well maybe if you guyz at MF actual did some DD you wouldn't sound so confused about ARIAD. There are a lot of good analysists you can talk with to help you understand ARIAD's potential, and how it is so undervalued at this time...someone like Mike King from JMP Securities could help you out If you need more info, I would be glad to help you out. Also, if you need a better cue card read, I could help with that as well!!


Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2191708, ~/Articles/ArticleHandler.aspx, 9/26/2016 5:22:50 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,094.83 -166.62 -0.91%
S&P 500 2,146.10 -18.59 -0.86%
NASD 5,257.49 -48.26 -0.91%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/26/2016 4:00 PM
ARIA $13.96 Up +0.44 +3.25%
Ariad Pharmaceutic… CAPS Rating: **
BMY $55.48 Down -1.00 -1.77%
Bristol-Myers Squi… CAPS Rating: ****
NVS $80.73 Down -0.75 -0.92%
Novartis CAPS Rating: ****